Insights

Strategic Merger Sumitomo Pharma America is consolidating US operations by merging seven subsidiaries with Sunovion as the remaining entity, signaling a unified commercial footprint and potential cross-sell opportunities across the combined portfolio.

R&D Collaboration Active collaboration with PsychoGenics on Ulotaront for schizophrenia positions Sunovion as a partner in innovative CNS programs, suggesting outreach to researchers and specialty clinics involved in antipsychotic development and psychosis care.

Product Lifecycle Past and ongoing product transitions, including LATUDA exclusivity concerns and gemtesa launches via co-promotion, indicate opportunities to engage with payers, clinicians, and specialty pharmacies during product lifecycle management and launches.

Digital & Ops Readiness Investments in tech stack elements like Tableau, Qlik, Salesforce, and SAP Ariba point to a data-driven sales approach; leverage analytics for target prioritization, segmentation, and streamlined procurement collaborations.

Market Positioning Revenue in the broad $1B–$10B band and a sizeable US presence imply competitive targeting for mid-to-large pharma partnerships, distribution deals, and co-promotion opportunities with aligned specialty portfolios.

Similar companies to Sunovion Pharmaceuticals

Daiichi Sankyo Japan
1.8K$1B - $10B
Lundbeck
6K$1B - $10B
Astellas Pharma
12K$10B+
Glenmark Pharmaceuticals
16K$1B - $10B
Intra-Cellular Therapies
592$500M - $1B

Sunovion Pharmaceuticals Tech Stack

Sunovion Pharmaceuticals uses 8 technology products and services including Qlik, Tableau, Contentful, and more. Explore Sunovion Pharmaceuticals's tech stack below.

Qlik
Business Intelligence
Tableau
Business Intelligence
Contentful
Content Management System
Salesforce
Customer Relationship Management
Oracle E-Business Suite
Enterprise Resource Planning
Azure Active Directory
Identity And Access Management
Microsoft Azure
Platform As A Service
SAP Ariba
Procurement

Media & News

Sunovion Pharmaceuticals's Email Address Formats

Sunovion Pharmaceuticals uses at least 4 email formats:

Sunovion Pharmaceuticals Email Formats	Example	Percentage
First.Last@sunovion.com	John.Doe@sunovion.com	91%
FLast@sunovion.com	JDoe@sunovion.com	6%
Last.First@sunovion.com	Doe.John@sunovion.com	2%
First.Middle@sunovion.com	John.Michael@sunovion.com	1%

Frequently Asked Questions

What is Sunovion Pharmaceuticals's phone number?

You can contact Sunovion Pharmaceuticals's main corporate office by phone at

+1-201-592-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Sunovion Pharmaceuticals's stock symbol?

Sunovion Pharmaceuticals is a publicly traded company; the company's stock symbol is SEPR.

What is Sunovion Pharmaceuticals's official website and social media links?

Sunovion Pharmaceuticals's official website is sunovion.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Sunovion Pharmaceuticals generate?

As of August 2026, Sunovion Pharmaceuticals's annual revenue is estimated to be $1B - $10B.

What is Sunovion Pharmaceuticals's NAICS code?

Sunovion Pharmaceuticals's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Sunovion Pharmaceuticals have currently?

As of August 2026, Sunovion Pharmaceuticals has approximately 909 employees across 4 continents, including North America, Europe and Asia. Key team members include Chief Executive Officer: J. O., Chief Information Officer, Vice President Head Of It: E. K. and Head Of It Business Systems: C. R. Explore Sunovion Pharmaceuticals's employee directory with LeadIQ.

What industry does Sunovion Pharmaceuticals belong to?

Sunovion Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Sunovion Pharmaceuticals use?

Sunovion Pharmaceuticals's tech stack includes Qlik, Tableau, Contentful, Salesforce, Oracle E-Business Suite, Azure Active Directory, Microsoft Azure and SAP Ariba.

What is Sunovion Pharmaceuticals's email format?

Sunovion Pharmaceuticals's email format typically follows the pattern of First.Last@sunovion.com. Find more Sunovion Pharmaceuticals email formats with LeadIQ.

When was Sunovion Pharmaceuticals founded?

Sunovion Pharmaceuticals was founded in 2010.

Sunovion Pharmaceuticals

Q: What is Sunovion Pharmaceuticals's official website and social media links?

Sunovion Pharmaceuticals's official website is sunovion.com. Sunovion Pharmaceuticals has social profiles on LinkedIn.

Q: How many employees does Sunovion Pharmaceuticals have currently?

Sunovion Pharmaceuticals has approximately 909 employees.

Q: What technology does Sunovion Pharmaceuticals use?

Sunovion Pharmaceuticals's tech stack includes R Project, SAS, Microsoft Office, OAuth, Microsoft 365.

Q: What is Sunovion Pharmaceuticals's NAICS code?

Sunovion Pharmaceuticals's NAICS code is 3254 (Pharmaceutical and Medicine Manufacturing).

Pharmaceutical ManufacturingUnited States501-1000 Employees

Sepracor is a United States-based pharmaceutical manufacturing company. It employs between 501 and 1000 people and maintains a web presence at sunovion.com. The company is described as having transitioned to Sumitomo Pharma America (SMPA). In 2023, Sumitomo Pharma merged its U.S. subsidiaries with Sunovion Pharmaceuticals Inc., consolidating into a single U.S. entity with Sunovion as the remaining company, reflecting the corporate restructuring described in the provided information. Related activities within the broader Sunovion/SMPA network include collaborations and product launches such as a partnership with PsychoGenics on Ulotaront for schizophrenia, and Gemtesa's launch in the U.S., indicating ongoing pharmaceutical development and commercialization work within the group.